Keywords: cephalon, sales, beat, its, expectations, drugmaker, reported
Cephalon's 2007 sales beat its expectations
Article | 25 February 2008
US drugmaker Cephalon reported that 2007 sales were slightly better than level with last year's $1.72 billion, exceeding the company's previously-issued guidance, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
